|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Operating activities | |
| Net loss | |
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities | |
| Depreciation and amortization | |
| Share-based compensation | |
| Loss on debt extinguishment | |
| Loss on disposal of property and equipment | |
| Amortization of debt issuance costs | |
| Non-cash operating lease expense | |
| Change in fair value of warrants | |
| Provision for credit losses | |
| Amortization of deferred commissions | |
| Changes in operating assets and liabilities | |
| Accounts receivable | |
| Inventory | |
| Prepaid expenses and other current assets | |
| Deferred commissions | |
| Other non-current assets | |
| Accounts payable | |
| Operating lease liabilities | |
| Accrued expenses and other current liabilities | |
| Deferred revenue | |
| Other non-current liabilities | |
| Net cash provided by (used in) operating activities | |
| Investing activities | |
| Purchases of property and equipment | |
| Capitalized internal-use software costs | |
| Net cash used in investing activities | |
| Financing activities | |
| Proceeds from issuance of Midcap term facility | |
| Payment of Midcap term facility issuance costs | |
| Repayment of term facility | |
| Members for Perceptive Term Loan Facility | |
| Midcap Term Facility | |
| Proceeds from exercise of stock options | |
| Payment of deferred offering costs | |
| Payment of debt extinguishment costs | |
| Net cash provided by (used in) financing activities | |
| Net increase (decrease) in cash and cash equivalents | |
| Cash and cash equivalents at beginning of period | |
| Cash and cash equivalents at end of period | |
| Supplemental disclosure of cash flow information | |
| Interest | |
| Supplemental disclosure of noncash investing and financing activities | |
| Share-based compensation expense capitalized in internal-use software | |
| Unpaid deferred offering costs included in accounts payable | |
| Unpaid property and equipment included in accounts payable | |
| Net share settlement of redeemable convertible preferred stock warrant liability in connection with convertible preferred stock warrant exercise | |
| Series A | |
| Series B | |
| Series D | |
| Common Stock | |
| Conversion of redeemable convertible preferred stock in connection with initial public offering |
Loading...
